M1A.29X1 Drug-induced chronic gout, multiple sites, with tophus (tophi)

Name of the Condition

• Drug-Induced Chronic Gout, Multiple Sites, With Tophus (Tophi)

Summary

Drug-induced chronic gout, multiple sites, with tophus (tophi) is a form of arthritis resulting from prolonged elevated uric acid levels due to medication use, leading to recurrent joint inflammation and tissue damage across multiple joints. It is characterized by persistent symptoms and the presence of tophi—hard, urate crystal deposits—under the skin or in tissues.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in joints and tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

• Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
• Prolonged exposure to urate-raising drugs
• Pre-existing hyperuricemia or gout history
• Renal impairment affecting drug clearance

Symptoms

• Recurrent episodes of intense joint pain, often in the big toe, ankles, knees, or other joints
• Persistent swelling, redness, and warmth in affected joints
• Formation of tophi (hard, painless lumps) under the skin
• Stiffness and limited joint mobility
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis confirms urate crystals. Imaging (e.g., X-rays, ultrasound) may reveal joint damage or tophi. The presence of tophi and multiple affected sites supports the diagnosis.

Treatment Options

Treatment focuses on reducing uric acid levels and managing symptoms. Medications may include urate-lowering agents (e.g., allopurinol) and anti-inflammatory drugs (e.g., colchicine). Tophi may require surgical removal in severe cases. Lifestyle modifications, such as dietary changes, are often recommended.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and tophi may shrink or resolve. However, untreated or poorly managed cases can lead to joint damage and disability. Regular follow-up is essential to monitor uric acid levels and adjust treatment as needed.

Complications

• Chronic joint damage and deformity
• Kidney stones or renal impairment
• Increased risk of cardiovascular disease
• Persistent pain and reduced quality of life

Lifestyle & Prevention

• Avoid medications known to raise uric acid levels when possible
• Maintain a healthy weight and balanced diet
• Limit alcohol and high-purine foods (e.g., red meat, seafood)
• Stay hydrated to support uric acid excretion

When to Seek Professional Help

Seek medical attention if you experience severe joint pain, swelling, or fever, or if tophi develop or worsen. Prompt evaluation is crucial to prevent complications and adjust treatment.

Tips for Medical Coders

Document the presence of tophi and multiple affected sites to support the use of this code. Ensure clinical notes specify the drug-induced nature of the gout and the involvement of multiple joints. Verify that the code aligns with the documented diagnosis and treatment plan.